Schroders adjusts fund objectives in light of challenging markets
Schroders has changed the objectives of its Real Return funds as it believes market conditions have made it more difficult to achieve the funds’ targets.
In a note to the Australian Securities Exchange (ASX), the firm said real cash rates and bond yields had fallen substantially which meant seeking above-inflation returns were “significantly challenged”.
“Market conditions have progressively made it more difficult to consistently achieve both the return and risk objectives of our Real Returns fund,” it said.
“Until recently, we believed these were reasonable targets to pursue, however the COVID-19 pandemic has now tipped the balance.
“The pandemic is impacting economies and markets around the world to such an extent that we believe investors to recalibrate their return expectations.”
The Schroder Real Return CPI Plus 3.5% fund name had changed to Schroder Multi-Asset Income, Schroder Real Return CPI Plus 5% would be the Schroder Real Return, and Schroder Real Return (managed fund) would remain the same.
On the Schroder Real Return CPI Plus 3.5% fund, distribution payments would change from quarterly to monthly as investors were seeking more regular income and the maximum exposure to growth assets in the funds would decrease to minimise the volatility of returns.
The changes would take place from 1 March, 2021.
Fund changes for Schroder Real Return range
Recommended for you
Grant Hackett has been promoted from CEO of Generation Life to head up the wider Generation Development Group.
Tribeca Investment Partners has made a distribution hire from Australian Ethical in a newly-created role focused on the national intermediary market.
Asset managers may be urged to diversify their product ranges, but investment executives have warned any M&A deal should avoid simply filling gaps and instead consider long-term value creation.
Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equity firm.